Review of potential risk groups for coronavirus disease 2019 (COVID-19)

Naveed, Muhammad; Naeem, Muhammad; Rahman, Mujeeb Ur; Hilal, Mian Gul; Khel, Mian Adnan Kaka; Ali, Gohar; Hassan, Adil

doi:10.1016/j.nmni.2021.100849

Cited by 18 publications

(21 citation statements)

References 91 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most prevalent comorbidities in our study were hypertension, diabetes, cardiovascular conditions, and asthma. A similar pattern was also found in different studies where hypertension was the most prevalent co-morbidity followed by diabetes, heart diseases, and respiratory illnesses (53)(54)(55). Some other studies revealed the same pattern as mentioned earlier, with hypertension, diabetes, and cardiovascular diseases as the prime co-morbidities (56,57).…”

Section: Discussionsupporting

confidence: 85%

Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan

Ahmad

Beg

Majeed

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

The emergence of a pathogen responsible for a mysterious respiratory disease was identified in China and later called a novel coronavirus. This disease was named COVID-19. The present study seeks to determine the epidemiological and clinical characteristics of COVID-19 in Pakistan. This report will exhibit a linkage between epidemiology and clinical aspects which in turn can be helpful to prevent the transmission of the virus in Pakistan. A retrospective, multiple center study was performed by collecting the data from patients' with their demographics, epidemiological status, history of co-morbid conditions, and clinical manifestations of the disease. The data was collected from 31 public-sector and 2 private hospitals across Pakistan by on-field healthcare workers. A Chi-square test was applied to assess the relationship between categorical data entries. A total of 194 medical records were examined. The median age of these patients was found to be 34 years. A total of 53.6% active cases were present including 41.2% males and 12.4% females till the end of the study. Adults accounted for most of the cases (94.3%) of COVID-19. Fever (86.60%), cough (85.05%), fatigue (36.60%), dyspnea (24.74%), and gastrointestinal discomfort (10.31%) were among the most frequently reported signs and symptoms by the patients. However, 4.12% of the total patient population remained asymptomatic. The median duration of hospital stay was found to be 14 (0–19) days. The earliest source of the spread of the virus may be linked to the foreigners traveling to Pakistan. Spread among men was more as compared to women. A few cases were found to be positive, due to the direct contact with pets or livestock. Hypertension (7.73%), diabetes (4.64%), cardiovascular conditions (2.58%) were the most common co-morbidities. The percentage mortality was 2.50% with the highest mortality among elders.

show abstract

Section: Discussionsupporting

confidence: 85%

Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan

Ahmad

Beg

Majeed

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…We obtained information on a wide range of pre‐existing chronic condition defined as risk factors for severe COVID‐19. 12 The diagnostic codes we used to define these conditions are shown in Table S3 . We required at least two registrations from January 2017 until end of follow‐up to qualify as an existing underlying condition.…”

Section: Methodsmentioning

confidence: 99%

“…We obtained information on a wide range of pre‐existing chronic condition defined as risk factors for severe COVID‐19 12 . The diagnostic codes we used to define these conditions are shown in Table S3.…”

Section: Methodsmentioning

confidence: 99%

Pregnancy and risk of COVID‐19: a Norwegian registry‐linkage study

Magnus

Oakley

Gjessing

et al. 2021

BJOG

View full text Add to dashboard Cite

Objective To compare the risk of acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and contact with specialist healthcare services for coronavirus disease 2019 (COVID‐19) between pregnant and non‐pregnant women. Population or sample All women ages 15–45 living in Norway on 1 March 2020 ( n = 1 033 699). Methods We linked information from the national birth, patient, communicable diseases and education databases using unique national identifiers. Main outcome measure We estimated hazard ratios (HR) among pregnant compared to non‐pregnant women of having a positive test for SARS‐CoV‐2, a diagnosis of COVID‐19 in specialist healthcare, or hospitalisation with COVID‐19 using Cox regression. Multivariable analyses adjusted for age, marital status, education, income, country of birth and underlying medical conditions. Results Pregnant women were not more likely to be tested for or to a have a positive SARS‐CoV‐2 test (adjusted HR 0.99; 95% CI 0.92–1.07). Pregnant women had higher risk of hospitalisation with COVID‐19 (HR 4.70, 95% CI 3.51–6.30) and any type of specialist care for COVID‐19 (HR 3.46, 95% CI 2.89–4.14). Pregnant women born outside Scandinavia were less likely to be tested, and at higher risk of a positive test (HR 2.37, 95% CI 2.51–8.87). Compared with pregnant Scandinavian‐born women, pregnant women with minority background had a higher risk of hospitalisation with COVID‐19 (HR 4.72, 95% CI 2.51–8.87). Conclusion Pregnant women were not more likely to be infected with SARS‐CoV‐2. Still, pregnant women with COVID‐19, especially those born outside of Scandinavia, were more likely to be hospitalised. Tweetable abstract Pregnant women are at increased risk of hospitalisation for COVID‐19.

show abstract

“…Our findings revealed that 28% of COVID-19 patients had a medical history that included cardiovascular disease and hypertension, type 2 diabetes, respiratory and allergic diseases, autoimmune diseases and endocrine diseases. Similar studies found that hypertension was the most common comorbidity, followed by diabetes, heart disease and respiratory disease (Yang et al, 2020;Ahmad et al, 2021;Naveed et al, 2021). In addition, patients with a serious medical history such as hypertension, heart disease, diabetes mellitus, lung disease and cancer, are also at a greater risk of COVID-19 severity and fatality (Yang et al, 2020;Naveed et al, 2021).…”

Section: Discussionmentioning

confidence: 87%

The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications

Mellali

Haoud

Keltoum

et al. 2022

Egyptian Academic Journal of Biological Sciences. C, Physiology

View full text Add to dashboard Cite

As part of the fight against COVID 19, various phytochemicals obtained from medicinal plants and natural products are being explored as alternative and complementary solutions to treat contaminated patients. The current study aimed to evaluate the efficacy of one of the most popular: clove or "Syzygium aromaticum L." Materials and Methods: In this sense, we conducted a cross-sectional descriptive study of 100 patients between the ages of 21 and 80, diagnosed positive for Covid-19, between October 2020 and January 2021, and administered between 2 and 3 clove buds, twice daily. Results and discussion: Our study revealed that patients between the ages of 30 and 39 were the most affected, with women being the predominant (75%). The scanner showed a moderate Covid-19 attack (10-25%) in 72% of patients. Dried clove was used by 85% of patients, 81% of them noted an improvement in their overall condition after 48 hours of treatment. The use of clove is relatively significant with disease progression (p < 0,05). Indeed, complications were observed in the group of patients who did not use this medicinal plant. Conclusion: Clove appears to be effective in the fight against COVID-19. It can be used to prevent and control symptoms associated with SARS-CoV-2.

show abstract

Review of potential risk groups for coronavirus disease 2019 (COVID-19)

Cited by 18 publications

References 91 publications

Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan

Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan

Pregnancy and risk of COVID‐19: a Norwegian registry‐linkage study

The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications

Contact Info

Product

Resources

About